Top 25 Companies in Global Continuous Subcutaneous Insulin Infusion Market (2025–2035): Statistics Report Till 2035
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, the global continuous subcutaneous insulin infusion market size is projected to grow from USD 3.04 Billion in 2024 to USD 10.07 Billion by 2035, at a CAGR of 11.5 % during the forecast period 2025–2035. The global continuous subcutaneous insulin infusion market is driven by rising prevalence of diabetes, increasing adoption of insulin pumps, technological advancements, and growing demand for improved glycemic control and patient convenience.
Introduction
The global continuous subcutaneous insulin infusion market includes the use of insulin pump devices which provide continuous insulin delivery through subcutaneous administration for diabetes treatment. The market expansion happens because more people develop diabetes and more advanced insulin delivery systems receive market acceptance and technological progress delivers smart pumps plus continuous glucose monitoring functions. The emerging markets and developing wearable devices and simple-to-use devices and better healthcare access create new business possibilities. The market growth throughout the world happens because people become more aware of diabetes treatment and reimbursement systems support diabetes treatment and people want better blood sugar control.
March 2026: U.S. Food and Drug Administration granted clearance to MiniMed (spun out from Medtronic) for the MiniMed Flex, its smallest smartphone-controlled insulin pump featuring automated insulin delivery, strengthening the continuous subcutaneous insulin infusion (CSII) market, which includes insulin pump devices.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Continuous Subcutaneous Insulin Infusion Market.
Market Segmentation
Global Continuous Subcutaneous Insulin Infusion Market Size, Share, By Product (Patch Pumps, Tethered Pumps), By Patient Type (Diabetes Type 1, Diabetes Type 2), By End-use, and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035
Continuous Subcutaneous Insulin Infusion Market Size & Statistics
- The Market Size for Continuous Subcutaneous Insulin Infusion Was Estimated to be worth USD 3.04 Billion in 2024.
- The Market is Going to Expand at a CAGR of 11.5 % between 2025 and 2035.
- The Global Continuous Subcutaneous Insulin Infusion Market Size is anticipated to reach USD 10.07 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Continuous Subcutaneous Insulin Infusion Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Continuous Subcutaneous Insulin Infusion Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the continuous subcutaneous insulin infusion market. Asia Pacific is expected to grow fastest due to the region possesses advanced healthcare facilities and most patients use insulin pump systems and the local medical system supports treatment expenses while diabetes cases are on the rise.
North America is expected to generate the highest demand during the forecast period in the continuous subcutaneous insulin infusion market. North America is expected to generate the highest demand due to the region possesses advanced healthcare facilities and most patients use insulin pump systems and the local medical system supports treatment expenses while diabetes cases are on the rise.
Ready to lead the Continuous Subcutaneous Insulin Infusion Market
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Continuous Subcutaneous Insulin Infusion Market
- AI-integrated insulin pumps for automated dosing
- Integration with Continuous Glucose Monitoring (CGM) systems
- Growing demand for patch (tubeless) insulin pumps
- Increasing focus on personalized diabetes management
- Expansion of smartphone-controlled insulin pumps
- Shift toward home-based diabetes care
- Rising global prevalence of diabetes
- Development of closed-loop (artificial pancreas) systems
- Favorable government support and reimbursement policies
- Advancements in wearable and connected insulin delivery devices
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Continuous Subcutaneous Insulin Infusion Market.
- AI-integrated insulin pumps for automated dosing
Artificial intelligence technology enables insulin pumps to deliver automated insulin based on current glucose measurements. The systems use advanced algorithms to forecast glucose changes which result in automatic insulin dose adjustments that decrease hypoglycemia and hyperglycemia hazards. The current trend leads to improved treatment results while reducing requirements for ongoing medical assistance to patients.
- Integration with Continuous Glucose Monitoring (CGM) systems
The systems track glucose levels in real-time while they connect to insulin pumps to deliver accurate insulin doses through automatic communication. The system exchanges real-time data which increases accuracy and helps better decision-making while creating the essential framework for closed-loop systems.
- Growing demand for patch (tubeless) insulin pumps
The small tubeless design of Patch pumps enables users to operate the device with better comfort than traditional pumps which require more space. The devices attach directly to skin surfaces without needing external tubes which allows users to maintain stealthy and practical operation especially during physical activities or for younger users.
- Increasing focus on personalized diabetes management
Diabetes treatment now shows a trend toward developing customized treatment methods for each patient. CSII devices now allow customization of insulin delivery based on patient-specific factors such as lifestyle, diet, activity levels, and glucose response patterns. The customized treatment approach leads to better blood sugar management results and higher levels of patient contentment.
- Expansion of smartphone-controlled insulin pumps
Insulin pumps now feature smartphone application integration which allows users to track their blood sugar levels, manage their insulin dosage, and retrieve information from remote locations. The system enables patients to participate more actively while making device functions simpler and allowing medical professionals to monitor patient information which leads to improved healthcare choices.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the continuous subcutaneous insulin infusion market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 25 Companies Leading the Continuous Subcutaneous Insulin Infusion Market
- Medtronic
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- Hoffmann-La Roche Ltd
- Ypsomed Holding AG
- Braun SE
- BD (Becton, Dickinson and Company)
- CeQur SA
- Johnson & Johnson
- Cellnovo Group SA
- SOOIL Development Co., Ltd.
- Valeritas Holdings, Inc.
- MicroPort Scientific Corporation
- Debiotech SA
- Beta Bionics, Inc.
- Bigfoot Biomedical, Inc.
- Diabeloop SA
- DreaMed Diabetes Ltd.
- Medtrum Technologies Inc.
- ViCentra B.V.
- Eli Lilly and Company
- Novo Nordisk A/S
- Sanofi
- Abbott Laboratories
- Pancreum, Inc.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Continuous Subcutaneous Insulin Infusion Market.
- Medtronic
Headquarters: Galway, Ireland
Medtronic operates as a leading medical technology firm which develops healthcare solutions that include advanced insulin delivery systems for diabetes management. The company operates in more than 150 countries to develop new medical devices and therapies which help patients achieve better health results. The diabetes division of the company which includes MiniMed insulin pumps leads the Continuous Subcutaneous Insulin Infusion CSII market through its complete solutions that work with continuous glucose monitoring systems.
- Insulet Corporation
Headquarters: Acton, Massachusetts, USA
Insulet Corporation operates as a major medical device manufacturer which creates innovative insulin delivery systems to make diabetes management easier for patients. The company developed the Omnipod system which serves as a tubeless insulin pump that patients can wear to replace their need to do multiple daily insulin injections. Insulet develops patient-friendly products while it creates new products and connects its digital systems to develop insulin delivery systems which make treatment easier for patients.
- Tandem Diabetes Care, Inc.
Headquarters: San Diego, California, USA
Tandem Diabetes Care operates as a medical device manufacturer which produces insulin delivery equipment to help people with diabetes control their condition. The company develops its advanced insulin pumps which include t slim X2 and Mobi systems to work with continuous glucose monitoring while employing hybrid closed-loop technology. The company creates new insulin infusion solutions which enable users to achieve better results through its focus on user experience and digital system connections.
- Hoffmann-La Roche Ltd
Headquarters: Basel, Switzerland
- Hoffmann-La Roche Ltd operates as an international healthcare organization which develops pharmaceutical products and diagnostic tests. The diabetes care division of Roche delivers diabetes management solutions through its blood glucose monitoring systems and insulin delivery products. The company provides integrated care services which combine diagnostic tests and treatment solutions while its advanced monitoring technologies support the CSII ecosystem.
5.Ypsomed Holding AG
Headquarters: Burgdorf, Switzerland
Ypsomed Holding AG functions as a Swiss medical technology company that creates and produces injection systems and infusion systems which patients use for self-administered diabetes treatments. The company provides insulin pumps together with supporting delivery systems which patients find easy to operate while maintaining their independence. Ypsomed operates as a leading innovation company which produces high-quality engineering solutions while establishing itself in international diabetes management markets.
Are you ready to discover more about the continuous subcutaneous insulin infusion market?
The report provides an in-depth analysis of the leading companies operating in the global continuous subcutaneous insulin infusion market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Medtronic
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- Hoffmann-La Roche Ltd
- Ypsomed Holding AG
- Braun SE
- BD (Becton, Dickinson and Company)
- CeQur SA
- Johnson & Johnson
- Others.
Conclusion
The global continuous subcutaneous insulin Infusion (CSII) market demonstrates continuous growth because diabetes rates are increasing and people need better insulin delivery systems. The development of AI-integrated pumps and continuous glucose monitoring (CGM) systems and closed-loop systems brings major improvements to patient results and treatment efficiency. North America leads the market because it has excellent healthcare systems and people widely use its services while Asia Pacific takes the lead as the fastest-growing area because of its better healthcare services and increased public knowledge about health. The market growth will increase because home healthcare services receive more support through reimbursement policies. The CSII market will grow strongly because ongoing product development and personalized diabetes care solutions gain more attention from customers.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Continuous Subcutaneous Insulin Infusion Market.
Our Reports:
Asia Pacific LPG Market Size, Scope, Research Report to 2035
Australia Gummy Market Size, Scope, Research Report to 2035
Advanced Molecular Nuclear Imaging Market Size, Growth to 2035
Generative AI in Packaging Market Size, Forecast to 2035
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?